Pure Global

Single-center study of MR-guided accelerated partial breast irradiation for low-risk breast cancer - Trial UMIN000052339

Access comprehensive clinical trial information for UMIN000052339 through Pure Global AI's free database. This Phase 2 trial is sponsored by National Cancer Center and is currently Not yet recruiting. The study focuses on breast cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000052339
Phase 2
Not yet recruiting
other
Trial Details
University Hospital Medical Information Network โ€ข UMIN000052339
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Single-center study of MR-guided accelerated partial breast irradiation for low-risk breast cancer

Study Focus

breast cancer

Interventional

other

Sponsor & Location

National Cancer Center

Japan

Timeline & Enrollment

Phase 2

Oct 15, 2023

N/A

ICD-10 Classifications

Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Malignant neoplasm: Breast, unspecified
Other carcinoma in situ of breast

Data Source

University Hospital Medical Information Network

UMIN000052339

Non-Device Trial